Skip to Main content Skip to Navigation
Journal articles

Synthesis and biological evaluation of bicyclic nucleosides as inhibitors of M. tuberculosis thymidylate kinase.

Abstract : Herein we describe the synthesis and conformational analysis of a series of bicyclic thymidine derivatives and their evaluation as inhibitors of thymidine monophosphate kinase from Mycobacterium tuberculosis (TMPKmt), based on previously discovered bicyclic sugar nucleosides. With a K(i) value of 2.3 microm, 1-[3-aminomethyl-3,5-dideoxy-2-O,6-N-(thiocarbonyl)-beta-D-ribofuranosyl]thymine emerged as the most potent TMPK inhibitor of this series. Moreover, this promising compound displays inhibitory potency against Mycobacteria cultures with an IC(99) value of 100 microg mL(-1), thus promoting TMPKmt for the first time as a validated target for further inhibitory design. Attempts to rationalise the observed structure-activity relationship (SAR) involving molecular modelling and conformational analysis are described.
Document type :
Journal articles
Complete list of metadatas

https://hal-pasteur.archives-ouvertes.fr/pasteur-00166946
Contributor : Hélène Munier-Lehmann <>
Submitted on : Monday, August 13, 2007 - 4:05:16 PM
Last modification on : Monday, January 13, 2020 - 5:08:08 PM

Links full text

Identifiers

Collections

Citation

Ineke van Daele, Hélène Munier-Lehmann, Pieter M S Hendrickx, Gilles Marchal, Pierre Chavarot, et al.. Synthesis and biological evaluation of bicyclic nucleosides as inhibitors of M. tuberculosis thymidylate kinase.. ChemMedChem, Wiley-VCH Verlag, 2006, 1 (10), pp.1081-90. ⟨10.1002/cmdc.200600028⟩. ⟨pasteur-00166946⟩

Share

Metrics

Record views

105